This is the authors' abstract. We don't add key points for this paper.
Chronic kidney disease affects approximately 9.5% of the global population, with end-stage kidney disease requiring renal replacement therapy (RRT). This narrative review synthesizes evidence from recent meta-analyses and landmark studies comparing psychological and psychosocial outcomes across hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KTx). Depression prevalence is approximately 35% in both HD and PD patients, but significantly lower (25%) in KTx recipients, a difference primarily attributable to modality rather than patient characteristics. Cognitive impairment affects 53% of HD patients versus lower rates in PD patients; intradialytic cerebral ischemia emerges as a plausible mechanism, yet paradoxically, PD patients show faster brain atrophy while maintaining better cognitive test performance. Health-related quality of life follows a consistent hierarchy: KTx provides superior outcomes, followed by PD, then HD, with effects most pronounced in kidney-disease-specific domains. Critically, immunosuppressive medication side effects, not graft function, emerge as the strongest predictor of post-transplant quality of life. Major psychosocial domains including employment, sexual function, and sleep quality remain unstudied when stratified by modality. Current modality selection relies on clinical and logistical factors without considering psychological fit. This review identifies substantial evidence gaps and proposes that future practice integrate psychological assessment into pre-dialysis education and develop validated tools to personalize modality selection based on coping capacity and psychological resilience.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zienkiewicz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: